Related Experiment Videos
[Cardiogenic shock: pathophysiology, clinics, therapeutical options and perspectives]
R Prondzinsky1, K Werdan, M Buerke
1Universitätsklinik und Poliklinik für Innere Medizin III, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale. roland.prondzinsky@medizin.uni-halle.de
Der Internist
|March 5, 2004
Summary
Mortality from myocardial infarction (MI) has decreased, but cardiogenic shock following acute MI remains deadly. Prompt percutaneous coronary intervention (PCI) offers the best hope for reducing mortality in these high-risk patients.
Area of Science:
- Cardiology
- Critical Care Medicine
Context:
- Mortality from myocardial infarction (MI) has significantly decreased due to advancements in treatment.
- However, mortality rates for cardiogenic shock post-MI remain critically high (70-80%).
- Myocardial failure leading to cardiogenic shock and multi-organ failure is the primary cause of in-hospital MI mortality.
Purpose:
- To highlight the persistent high mortality associated with cardiogenic shock following acute myocardial infarction.
- To emphasize the critical need for improved treatment strategies for this specific patient group.
Summary:
- While overall MI mortality has fallen, cardiogenic shock outcomes have not improved.
- Facilitated or adjunctive percutaneous coronary intervention (PCI) is identified as the leading strategy to reduce mortality.
- Facilitated PCI encompasses therapies like glycoprotein receptor antagonists and mechanical circulatory support, including intra-aortic balloon counterpulsation.
Impact:
- This research underscores the urgent need for further investigation and implementation of advanced therapies for cardiogenic shock.
- Improved management of cardiogenic shock post-MI could significantly reduce in-hospital mortality.
- The findings advocate for the adoption of facilitated PCI as a cornerstone treatment for acute MI complicated by cardiogenic shock.